| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-06-1313 |
| P698 | PubMed publication ID | 17200371 |
| P50 | author | Paul A Grayburn | Q87446651 |
| Jason Fleming | Q96250261 | ||
| P2093 | author name string | Juliet G Carbon | |
| Rolf A Brekken | |||
| Grzegorz Korpanty | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microbubble | Q6839290 |
| P304 | page(s) | 323-330 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature | |
| P478 | volume | 13 |
| Q84045720 | A simple method for quantifying ultrasound-triggered microbubble destruction |
| Q30449927 | Acoustic angiography: a new imaging modality for assessing microvasculature architecture |
| Q38027851 | Advances in image-guided intratumoral drug delivery techniques |
| Q33926491 | Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs |
| Q30458500 | An animal model allowing controlled receptor expression for molecular ultrasound imaging. |
| Q52915643 | Animal models of pancreatic cancer for drug research. |
| Q30474689 | Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). |
| Q38218986 | Antibody-based imaging strategies for cancer. |
| Q34284723 | Anti‐VEGF Therapy in Breast and Lung Mouse Models of Cancers |
| Q34290118 | Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer |
| Q84974591 | Bioeffects of ultrasound-stimulated microbubbles on endothelial cells: gene expression changes associated with radiation enhancement in vitro |
| Q34050525 | Bioluminescence imaging of angiogenesis in a murine orthotopic pancreatic cancer model |
| Q30416864 | Biomarkers in preclinical cancer imaging. |
| Q37764089 | CD105 is a marker of tumour vasculature and a potential target for the treatment of head and neck squamous cell carcinoma |
| Q30441894 | Cellular characterization of ultrasound-stimulated microbubble radiation enhancement in a prostate cancer xenograft model |
| Q28080671 | Challenges of Pancreatic Cancer |
| Q40026377 | Chapter 7. Molecular imaging of tumor vasculature |
| Q39227976 | Characterization of tumor vasculature distributions in central and peripheral regions based on Doppler ultrasound |
| Q39042485 | Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma. |
| Q30368922 | Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions. |
| Q30478135 | Contrast enhanced endoscopic ultrasound: More than just a fancy Doppler |
| Q37871463 | Contrast ultrasound and targeted microbubbles: diagnostic and therapeutic applications for angiogenesis |
| Q30426253 | Contrast-enhanced harmonic endoscopic ultrasound imaging: basic principles, present situation and future perspectives |
| Q30365045 | Contrast-enhanced harmonic endoscopic ultrasound: Future perspectives |
| Q53420337 | Contrast-enhanced molecular ultrasound differentiates endoglin genotypes in mouse embryos. |
| Q37749577 | Contrast-enhanced ultrasound for molecular imaging of angiogenesis |
| Q37970228 | Contrast-enhanced ultrasound in oncology |
| Q30435874 | Current status and prospects for microbubbles in ultrasound theranostics |
| Q91784063 | Development of 68Ga-labelled ultrasound microbubbles for whole-body PET imaging |
| Q37229410 | Doppler ultrasonography reveals blood flow signals within the masses of invasive moles in subjects with normal hCG levels after chemotherapy: Three case reports |
| Q36295224 | Dose-response relationship of ultrasound contrast agent in an in vivo murine melanoma model |
| Q30484195 | Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo |
| Q33738469 | Effect of Fe(3)O(4)-magnetic nanoparticles on acute exercise enhanced KCNQ(1) expression in mouse cardiac muscle |
| Q37222721 | Effect of chronic morphine on the dentate gyrus neurogenic microenvironment |
| Q38074721 | Endoglin for tumor imaging and targeted cancer therapy. |
| Q37804900 | Endoglin-Targeted Cancer Therapy |
| Q37895953 | Engineered nanoparticles for biomolecular imaging |
| Q30464428 | Fast microbubble dwell-time based ultrasonic molecular imaging approach for quantification and monitoring of angiogenesis in cancer |
| Q30470286 | Formulation and characterization of echogenic lipid-Pluronic nanobubbles |
| Q30275458 | Imaging in pancreatic disease |
| Q30446280 | Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice |
| Q36469164 | Imaging of tumor angiogenesis: functional or targeted? |
| Q36185354 | ImmunoPET and near-infrared fluorescence imaging of CD105 expression using a monoclonal antibody dual-labeled with (89)Zr and IRDye 800CW. |
| Q57575147 | Improved Sensitivity in Ultrasound Molecular Imaging With Coherence-Based Beamforming |
| Q35291271 | In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis |
| Q58785326 | InVivo Molecular Ultrasound Assessment of Glioblastoma Neovasculature with Endoglin-Targeted Microbubbles |
| Q30465487 | Intravascular targets for molecular contrast-enhanced ultrasound imaging |
| Q35018333 | Label-free optical imaging of lymphatic vessels within tissue beds in vivo |
| Q89057019 | Layered acoustofluidic resonators for the simultaneous optical and acoustic characterisation of cavitation dynamics, microstreaming, and biological effects |
| Q30459779 | Leveraging the power of ultrasound for therapeutic design and optimization |
| Q30404351 | Manipulating nanoscale features on the surface of dye-loaded microbubbles to increase their ultrasound-modulated fluorescence output. |
| Q30465343 | Model system using controlled receptor expression for evaluating targeted ultrasound contrast agents |
| Q37039546 | Molecular MR imaging of neovascular progression in the Vx2 tumor with αvβ3-targeted paramagnetic nanoparticles |
| Q42121924 | Molecular and clinical aspects of targeting the VEGF pathway in tumors. |
| Q44035899 | Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38). |
| Q22122025 | Molecular imaging in drug development |
| Q30479243 | Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques? |
| Q37752025 | Molecular imaging with contrast enhanced ultrasound |
| Q30474579 | Molecular imaging: current status and emerging strategies |
| Q30474770 | Molecular ultrasound assessment of tumor angiogenesis |
| Q37777365 | Molecular ultrasound imaging and its potential for paediatric radiology |
| Q30474725 | Molecular ultrasound imaging: current status and future directions |
| Q30452632 | Monitoring antivascular therapy in head and neck cancer xenografts using contrast-enhanced MR and US imaging |
| Q37949294 | Multifunctional microbubbles and nanobubbles for photoacoustic imaging |
| Q30476445 | Multimodality molecular imaging of CD105 (Endoglin) expression |
| Q41667212 | Nilotinib Enhances Tumor Angiogenesis and Counteracts VEGFR2 Blockade in an Orthotopic Breast Cancer Xenograft Model with Desmoplastic Response |
| Q33933009 | Parametric contrast-enhanced ultrasound as an early predictor of radiation-based therapeutic response for lymph node metastases of nasopharyngeal carcinoma |
| Q30480282 | Plasmonic nanoparticle-generated photothermal bubbles and their biomedical applications |
| Q35809541 | Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody. |
| Q35017120 | Positron emission tomography imaging of CD105 expression during tumor angiogenesis. |
| Q35587248 | Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105. |
| Q36034526 | Positron emission tomography imaging of tumor angiogenesis with a 66Ga-labeled monoclonal antibody. |
| Q36746567 | Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121. |
| Q30465292 | Preclinical Lymphatic Imaging |
| Q90618474 | Preclinical Molecular Imaging for Precision Medicine in Breast Cancer Mouse Models |
| Q30475818 | Preclinical molecular imaging of tumor angiogenesis. |
| Q30448551 | Preparation of targeted microbubbles: ultrasound contrast agents for molecular imaging |
| Q39941113 | Quantitative PET imaging of VEGF receptor expression |
| Q50903873 | Quantitative ultrasound molecular imaging. |
| Q30436709 | Recent advances in molecular, multimodal and theranostic ultrasound imaging |
| Q30419728 | Recent developments in dynamic contrast-enhanced ultrasound imaging of tumor angiogenesis |
| Q39979176 | Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model |
| Q37389699 | Selecting Tumor-Specific Molecular Targets in Pancreatic Adenocarcinoma: Paving the Way for Image-Guided Pancreatic Surgery |
| Q53132563 | Sentinel Lymph Node Characterization with a Dual-Targeted Molecular Ultrasound Contrast Agent. |
| Q30357817 | Squamous Cell Carcinoma Xenografts: Use of VEGFR2-targeted Microbubbles for Combined Functional and Molecular US to Monitor Antiangiogenic Therapy Effects. |
| Q36158355 | Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles |
| Q35086518 | Targeted antiangiogenesis gene therapy using targeted cationic microbubbles conjugated with CD105 antibody compared with untargeted cationic and neutral microbubbles |
| Q53602378 | Targeted contrast-enhanced ultrasound imaging of angiogenesis in an orthotopic mouse tumor model of renal carcinoma. |
| Q22255481 | Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides. |
| Q37133833 | Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice. |
| Q38364441 | Targeted ultrasound contrast agents for ultrasound molecular imaging and therapy |
| Q37610628 | Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours |
| Q47234214 | Targeting of microbubbles: contrast agents for ultrasound molecular imaging. |
| Q58568681 | The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II) |
| Q45339905 | The effect of binding on the subharmonic emissions from individual lipid-encapsulated microbubbles at transmit frequencies of 11 and 25 MHz. |
| Q54969144 | Thyroid Cancer Detection by Ultrasound Molecular Imaging with SHP2-Targeted Perfluorocarbon Nanoparticles. |
| Q30431243 | US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice |
| Q49774225 | Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results |
| Q48283222 | Ultrasound Molecular Imaging and Drug Delivery |
| Q30359568 | Ultrasound Molecular Imaging of Angiogenesis Using Vascular Endothelial Growth Factor-Conjugated Microbubbles. |
| Q30432690 | Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. |
| Q30422129 | Ultrasound molecular imaging of vascular endothelial growth factor receptor 2 expression for endometrial receptivity evaluation |
| Q30445036 | Ultrasound molecular imaging with targeted microbubble contrast agents |
| Q30375187 | Ultrasound molecular imaging: Moving toward clinical translation |
| Q30405170 | Ultrasound-modulated fluorescence based on fluorescent microbubbles |
| Q38969661 | Use of VEGFR-2 targeted ultrasound contrast agent for the early evaluation of response to sorafenib in a mouse model of hepatocellular carcinoma. |
| Q30455612 | Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy |
| Q30725740 | Visualization, imaging and new preclinical diagnostics in radiation oncology |
| Q30411800 | Whole animal imaging |
| Q83334456 | [Assessment of tumour angiogenesis using contrast-enhanced ultrasound] |
| Q53448099 | [Recent advances in contrast-enhanced ultrasound for oncology applications] |
| Q30425448 | scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis |
Search more.